Company
Quanterix
Powering Biomarkers from Discovery to Diagnostics
Also known as QUANTERIX CORP
- Status
- IPOas of 2026-09-23Source (opens in a new tab)
- Business model
- B2B
- Headquarters
- Billerica, MA, United States
- Customers
- academic and industry customers, top 20 pharma, CROs, and diagnostics labs, researchers, scientists and healthcare providers
- Legal name
- QUANTERIX CORP
Claim, correct or request removal
Record updated 28 September 2026
About
Quanterix (NASDAQ:QTRX) is a public Life Science Tools company located in Billerica, MA. It develops and sells uniquely precise and sensitive instrumentation to analyze and detect biomolecules for a variety of life sciences research and diagnostic applications. Public since December 2017.
Funding snapshot
- Total raised
- $71.8MSEC form D sum, as of 2026-09-28Source (opens in a new tab)
- Latest round
- Round, $6.2M2019-07-01
Funding rounds
- Round, 2019
- $6.2M2019-07-01, SEC form D sold, 3 investors
- Round, 2017
- $8.5M2017-06-02, SEC form D sold, 5 investors
- Round, 2016
- $45.6M2016-03-18, SEC form D sold, 15 investors
- Round, 2013
- $1000K2013-12-03, SEC form D sold, 1 investor
- Round, 2012
- $2M2012-03-01, SEC form D sold, 9 investors
- Round, 2011
- $6M2011-08-15, SEC form D sold, 9 investors
- Round, 2010
- $2.5M2010-09-28, SEC form D sold, 9 investors
About the company
- Status notes
- Public since December 2017
Products
- Web
- LucentAD blood test
- Web
- Simoa Accelerator Laboratory
- Web
- Simoa Assay Kits and Reagents
- Web
- Simoa Instruments
- Web
- Spatial Biology Assays & Reagents
- Web
- Spatial Biology Instruments
Loading relationship preview